中文 English

RISCare® Tumor Susceptibility Gene Detection

Detection method

  • - Next generation sequencing.

Test significance

  • - Cover 58 genes’ whole exons and partial introns.
  • - Use to evaluate the genetic risk of ovarian cancer, breast cancer, HBOC, prostate cancer, pancreatic cancer、Lynch syndrome and so on.

Product advantage

  • - Apply to blood or FFPE sample detection.

Detection of genes

Tumor genes(58)

  • APC
  • CDK12
  • FANCM
  • MUTYH
  • RAD51
  • ARID1A
  • CHEK1
  • GALNT12
  • NBN
  • RAD51B
  • ATM
  • CHEK2
  • GREM1
  • NF1
  • RAD51C
  • ATR
  • EMSY
  • HDAC2
  • NTHL1
  • RAD51D
  • AXIN2
  • EPCAM
  • HOXB13
  • PALB2
  • RAD54L
  • BARD1
  • ERCC3
  • MCPH1
  • PMS1
  • RPS20

Applicable to cancer patients

twst

Test procedure

*Product is for research use only.